Filter by: patients
What is Telmisartan?

Telmisartan is an angiotensin II receptor antagonist used alone or in combination with other medications to treat high blood pressure. Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Elevated blood pressure 19 4 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Hypertension 6 0
Other 4 0
Support circulatory health 2 0
General health 1 1 Efficacy_major
Support heart health 1 0

See all 39 patients currently taking Telmisartan

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
1
Mild
1
None
4

Commonly reported side effects, conditions, and hospitalizations associated with Telmisartan

Low blood pressure 1

Reported Dosages

  20 mg daily 40 mg daily 80 mg daily 160 mg daily
  4 Number of Patients: 4 17 Number of Patients: 17 17 Number of Patients: 17 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Telmisartan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 3   Did not seem to work: 50%
Side effects too severe 2   Side effects too severe: 33%
Other 1   Other: 17%

See all 6 patients who’ve stopped taking Telmisartan

Currently Taking Telmisartan

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Telmisartan

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Telmisartan

Always
6 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Telmisartan

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
6 100%

Cost

Paid out of pocket

Cost of Telmisartan

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.